BETA BIONICS INC.
Manufacturer adverse-event records for BETA BIONICS INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2024–2026 · heavy-book · quiet Death-code · balanced
Death-code intensity
BETA BIONICS INC. is quieter on Death-coded events
Death-coded event_type rows are 5 of 28,303 (0.02% · quiet tercile among 443 manufacturers). Absolute volume is heavy-book.
What the Death-code reading shows for BETA BIONICS INC.
The standout signal for BETA BIONICS INC. is Death-code intensity: 0.02% of 28,303 reports (quiet tercile), while absolute volume is heavy-book.
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair BETA BIONICS INC. with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 2 device types, led in this extract by Malfunction at 23,446 (82.8% of event_type total). Peak single-year volume reaches 15,603 reports across 3 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (2)
| Device | Reports |
|---|---|
| Alternate Controller Enabled Insulin Infusion Pump | 28,302 |
| Set, Administration, Intravascular | 1 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.